AMD and micronutrient antioxidants

Current Eye Research

Volumn 29, Issue 6, 2004, Pages 387-401

  Hogg, Ruth ^a   Chakravarthy, Usha ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Age related macular degeneration; Age related maculopathy; Antioxidants; Lutein; Macular pigment; Oxidative stress

Indexed keywords

ALPHA CAROTENE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BASIC FIBROBLAST GROWTH FACTOR; BETA CAROTENE; BETA CRYPTOXANTHIN; CAROTENOID; LYCOPENE; MULTIVITAMIN; OXIDIZED LOW DENSITY LIPOPROTEIN; RETINOL; SELENIUM; TRACE ELEMENT; XANTHOPHYLL; ZEAXANTHIN; ZINC;

AGE DISTRIBUTION; BLOOD SAMPLING; CIGARETTE SMOKING; CLINICAL FEATURE; DIET SUPPLEMENTATION; FRUIT; HEALTH STATUS; HUMAN; NUTRITION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; QUALITY OF LIFE; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; SEX DIFFERENCE; SHORT SURVEY; TREATMENT OUTCOME; VEGETABLE; VISUAL IMPAIRMENT; VITAMIN SUPPLEMENTATION;

ANTIOXIDANTS; CLINICAL TRIALS; DIET; HUMANS; LUTEIN; MACULAR DEGENERATION; MICRONUTRIENTS; NUTRITION PHYSIOLOGY; OXIDATIVE STRESS; RISK FACTORS;

EID: 12344332867     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1080/02713680490517890     Document Type: Short Survey

References (94)

1. Klein BEK, Klein R. Cataracts and macular degeneration in older Americans. Arch Ophthalmol. 1982;100:571-573.
2. Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, de Jong PT, Klaver CC, Klein BE, Klein R, Mitchell P, Sarks JP, Sarks SH, Soubrane G, Taylor HP, Vingerling JR. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol. 1995;39:367-374.
3. Gass JD. Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol. 1967;(Suppl)63:1-139.
4. Smith W, Assink J, Klein R, Mitchell P, Klaver CC, Klein BE, Hofman A, Jensen S, Wang JJ, de Jong PT. Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology. 2001;108:697-704.
5. Evans J, Wormald R. Is the incidence of registrable age-related macular degeneration increasing? Br J Ophthalmol. 1996;80:9-14.
6. Eye disease case control study group. Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol. 1992;110:1701-1710.
7. Macular photocoagulation study Group. Risk factors for choroidal neovascularization in the second eye of patients with juxta foveal or subfoveal choroidal neovascularization secondary to age related macular degeneration. Arch Ophthalmol. 1997;115:741-747.
8. Smith W, Mitchell P, Leeder SR. Smoking and age-related maculopathy. Arch Ophthalmol. 1996;114:1518-1523.
9. Tomany SC, Klein R, Klein BE. Beaver dam eye study. The relationship between iris color, hair color, and skin sun sensitivity and the 10-year incidence of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmol. 2003;110:1526-1533.
10. Silvestri G, Johnston PB, Hughes AE. Is genetic predisposition an important risk factor in age-related macular degeneration. Eye. 1994;8:564-568.
11. Klein R, Klein BE, Tomany SC, Cruickshanks KJ. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology. 2003;110:1273-1280.
12. Smith W, Mitchell P, Leeder SR, Wang JJ. Plasma fibrinogen levels, other cardiovascular risk factors and age-related maculopathy. The Blue Mountains Eye Study. Arch Ophthalmol. 1998;116:583-589.
13. Hyman L, Schachat AP, He Q, Leske MC. Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group. Arch Ophthalmol. 2000;118:351-358.
14. Seddon JM, Cote J, Davis N, Rosner B. Progression of age-related macular degeneration: Association with body mass index, waist circumference, and waist-hip ratio. Arch Ophthalmol. 2003;121:785-792.
15. Taylor HR, West S, Munoz B, Rosenthal FS, Bressler SB, Bressler NM. The long term effects of visible light on the eye. Arch Ophthalmol. 1992;110:99-104.
16. Zimmerman JA, Malloy V, Krajcik R, Orentreich N. Nutritional control of aging. Exp Gerontol 2003;38:47-52.
17. Mattison JA, Lane MA, Roth GS Ingram DK. Calorie restriction in rhesus monkeys. Exp Gerontol. 2003;38:35-46.
18. De Marte ML, Enesco HE. Influence of low tryptophan diet on survival and organ growth in mice. Mech Ageing Dev. 1986;36:161-171.
19. Kant AK, Schatzakin A, Graubard BI, Schairer C. A prospective study of diet quality and mortality in women. JAMA 2000;283:2109-2115.
20. Hu FB, Willett WC. Optimal diets for prevention of Coronary Heart Disease. JAMA 2002;288:2569-2257.
21. Simpooulos AR. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002;56:365-379.
22. Anderson JW, Hanna TJ, Peng X, Krysclo RJ. Whole grain foods and heart disease risk. J Am Coll Nutr. 2000;19(Suppl):291S-299S.
23. Fairfield KM, Fletcher RH. Vitamins for chronic disease prevention in adults. Scientific Review. JAMA 2002;287:3116-3126.
24. Harman D. The aging process. Proc Natl Acad Sci USA. 1981;78:7124-7128.
25. Mayne ST. Antioxidant nutrients and chronic disease: Use of biomarkers of exposure and oxidative stress status in epidemiologic research. J Nutr. 2003;133:933S-940S.
26. Handleman GJ, Dratz E. The role of antioxidants in the retina and retinal pigment epithelium and the nature of pro-oxidant induced damage. Adv Free Radic Biol Med. 1986;2:1-89.
27. Cai J, Nelson KC, Wu M, Sternberg P Jr, Jones DP. Oxidative damage and protection of the RPE. Prog Retinal Eye Res. 2000;19:205-221.
28. Beatty S, Koh HH, Henson D, Bolton M. The role of oxidative stress in the pathogenesis of Age-related Macular Degeneration. Surv Ophthalmol. 2000;45:115-134.
29. Roberts JE. Ocular phototoxicity. J Photochem Photobiol. 2001;64:136-143.
30. Winkler BS, Boulton ME, Gottsch JD, Sternberg P. Oxidative damage and age-related macular degeneration. Molecular Vision. 1999;5:32.
31. Landrum JT, Bone RA. Lutein, zeaxanthin, and the macular pigment. Arch Biochem Biophys. 2001;385:28-40.
32. Snodderly DM, Handelman GL, Adler AJ. Distribution of individual macular pigment carotenoids in the central retina of macaque and squirrel monkeys. Invest Ophthalmol Vis Sci. 2000;45:115-134.
33. Snodderly DM, Brown PK, Delori FC, Auran JD. The macular pigment. I Absorbance spectra, localization and discrimination form other yellow pigments in the primate retinas. Invest Ophthalmol Vis Sci. 1984;25:660-673.
34. Bone RA, Landrum JT, Friedes LM, Gomez CM, Kilburn MD, Menendez E, Vidai I, Wang W. Distribution of lutein and zeaxanthin stereoisomers in the human retina. Exp Eye Res. 1997;64:211-218.
35. Sommerburg OG, Siems WG, Hurst JS, Lewis JW, Kliger DS, van Kuijk FJ. Lutein and zeaxanthin are associated with photoreceptors in the human retina. Curr Eye Res. 1999;19:491-5.
36. Bone RA, Landrum JT, Mayne ST, Gomez CM, Tibor SE, Twaroska EE. Macular pigment in donor eyes with and without AMD: A case-control study. Invest Ophthalmol Vis Sci. 2001;42:235-240.
37. Bernstein PS, Zhao DY, Wintch SW, Ermakov IV, McClane RW, Gellermann W. Resonance raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients. Ophthalmology. 2002;109:1780-1787.
38. Beatty S, Murray IJ, Henson DB, Carden D, Koh H, Boulton ME. Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci. 2001;42:439-446.
39. Schalch W, Dayhaw-Barker P, Barker FM. The Carotenoids of human retina. In: Taylor A, Ed. Nutritional and environmental influences on the Eye. CRC Press, Boca Raton, pp. 215-249.
40. Krinsky NI. Carotenoids as antioxidants. Nutrition. 2001;17:815-817.
41. Blumenkranz MS, Russell SR, Robey MG, Kott-Blumenkranz R and Penneys N. Risk factors in age-related maculopathy complicated by choroidal neovascularisation. Ophthalmology. 1986;96:552-558.
42. EDCCS. Antioxidant status and neovascular age-related macular degeneration. Arch Ophthalmol. 1993;111:104-109.
43. Seddon JS, Ajani UA, Sperduto RD, Hiller R, Blair N, Burton TC, Farber MD, Evangelos GS, Haller J, Miller DT, Yanuzzi LA, Willet W. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. JAMA 1994;272:1413-1420.
44. Belda JI, Romá J, Vilela C, Puertas FJ, Díaz-Llopis M, Bosch-Morell F, Romero FJ. Serum vitamin E levels negatively correlate with the severity of age-related macular degeneration. Mech Ageing Dev. 1999;107:159-164.
45. Ishihara N, Yuzawa M, Tamakoshi A. Antioxidants and angiogenetic factor associated with age-related macular degeneration (exudative type). Nippo Ganka Gakkai Zasshi. 1997;3:248-251 (in Japanese).
46. Simonelli F, Zarrilli F, Mazzeo S, Verde V, Romano N, Savoia M, Testa F, Vitale DF, Rinaldi M, Sacchetti L. Serum oxidative and antioxidant parameters in a group of Italian patients with age-related maculopathy. Clin Chim Acta. 2002;320:111-115.
47. Snellen ELM, Verbeek ALM, van den Hoogen GWP, Cruysberg JRM, Hoyng CB. Neovascular age-related macular degeneration and its relationship to antioxidant intake. Acta Ophthalmol Scand. 2002;80:368-371.
48. Goldberg J, Flowerdew G, Smith E, Brody JA, Tso MOM. Factors associated with age-related macular degeneration. Am J Epidemiol. 1988;128:700-710.
49. Mares-Perlman JA, Fisher AI, Klein R, Palta M, Block G, Millen AE, Wright JD. Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third national health and nutrition examination survey. Am J Epidemiol. 2001;153:424-432.
50. Mares-Perlman JA, Brady WE, Klein R, Klein BEK, Bowen P, Stacewicz-sapuntzakis M and palta M serum antioxidants and age-related macular degeneration in a population-based case-control study. Arch Ophthlamol. 1995;113:1518-1523.
51. Saunders TAB, Haines AP, Wormald R, Wright LA, Obeid O. Essential fatty acids, plasma cholesterol, and fat- soluble vitamins in subjects with age-related maculopathy and matched control subjects. Am J Clin Nutr. 1993;57:428-433.
52. West S, Vitale S, Hallfrisch J, Muńoz B, Muller D, Bressler S, Bressler NM. Are antioxidants or supplements protective for age-related macular degeneration. Arch Ophthalmol. 1994;112:222-227.
53. Van den Langenberg GM, Mares-Perlman JA, Klein R, Klein BEK, Brady WE, Palta M. Association between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am J Epidemiol. 1998;148:204-214.
54. Mares-Perlman JA, Klein R, Klein BE, Greger JL, Brady WE, Palta M, Ritter LL. Association of zinc and antioxidant nutrients with age-related maculopathy. Arch Ophthalmol. 1996;114:991-997.
55. Smith W, Mitchell P, Rochester C. Serum beta carotene, alpha-tocopherol, and age-related maculopathy: The blue mountains eye study. Am J Ophthalmol. 1997;126:838-840.
56. Christen WG, Ajani UA, Glynn RJ, Manson JE, Schaumberg DA, Chew EC, Buring JE, Hennekens CH. Prospective cohort study of vitamin supplement use and the risk of age-related maculopathy. Am J Epidemiol. 1999;149:476-484.
57. Delcourt C, Cristol JP, Tessier F, Leger C, Descomps B, Papoz L. The POLA Study Group. Age-related macular degeneration and antioxidant status in the POLA study. Arch Ophthalmol. 1999;117:1384-1390.
58. Flood V, Smith W, Wang JJ, Manzi F, Webb K, Mitchell P. Dietary antioxidant intake and incidence of early age-related maculopathy. Ophthalmology. 2002;109:2272-2278.
59. Gale CR, Hall NF, Phillips DIW, Marytn CN. Lutein and zeaxanthin status and risk of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2003;44:2461-2465.
60. Vannas S, Orma H. On the treatment of arteriosclerotic chorioretinopathy. Acta Ophthalmol. 1958;36:601-612.
61. Stark H. Langzeitbehandlung der senilen makuladegeneration mit cosaldon A+E. Klin Monatsbi Augenheilkd. 1985;187:296-302.
62. Richer S. Part II: ARMD- Pilot (Case Series) environmental intervention data. J Am Optom Assoc. 1999;70:24-36.
63. Age-related Macular Degeneration Study Group. Multicenter ophthalmic and nutritional age-related degeneration study - part 1: Design, subjects and procedures. J Am Optom Assoc. 1996;67:12-29.
64. Age-related Macular Degeneration Study Group. Multicenter ophthalmic and nutritional age-related macular degeneration study - part 2: antioxidant intervention and conclusions. J Am Optom Assoc. 1996;67:30-49.
65. Bone RA, Landrum JT, Guerra LH, Ruiz CA. Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans. J Nutr. 2003;133:992-998.
66. Bernstein PS, Zhao DY, Wintch SW, Ermakov IV, McClane RW, Gellermann W. Resonance raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients. Ophthalmology. 2002;109:1780-1787.
67. Landrum JT, Bone RA, Joa H, Kilburn MD, Moore LL, Sprague KE. A one year study of the macular pigment: The effect of 140 days of a lutein supplement. Exp Eye Res. 1997;65:57-62.
68. Hammond BR, Johnson EJ, Russell RM, Krinsky NI, Yeum KJ, Edwards RB, Snodderly DM. Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci. 1997;38:1795-1801.
69. Berendschot TTJM, Goldbohm RA, Klöpping WAA, van de Kraats J, van Norel J, van Norren D. Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest Ophthalmol Vis Sci. 2000;41:3322-3326.
70. Newsome DA, Swartz M, Leone NC, Elston RC, Miller E. Oral zinc in macular degeneration. Arch Ophthalol. 1988;106:192-198.
71. Stur M, Tittl M, Reitner A, Meisinger V. Oral zinc and the second eye in age-related macular degeneration. Invest Ophthalmol Vis Sci. 1996;37:1225-1235.
72. Holz FG, Wolfensberger TJ, Piguet B, Groß-Jendroska M, Arden GB, Bird AC. Oral zinc therapy in age-related macular degeneration: A double-blind study. German J Ophthalmolo.. 1993;2:391.
73. Kaiser HJ, Flammer J, Stumpfig D, Hendrickson P. Visaline in the treatment of age-related macular degeneration - A pilot study. Ophthalmologica. 1995;209:302-305.
74. Teikari JM, Laatikainen L, Virtamo J, Haukka J, Rautalahti M, Liesto K, Albanes D, Taylor P, Heinonen OP Six-year supplementation with alpha-tocopherol and beta-carotene and age-related maculopathy. Acta Ophthalmol Scand. 1998;76:224-229.
75. Taylor HR, Tikellis G, Robman LD, McCarry CA, McNeil JJ. Vitamin E supplementation and macular degneration: Randomised controlled trial. BMJ 2002;11:325.
76. Tikellis G, Robman LD, Harper CA, Garrett SKM, McNeil JJ, Taylor HR, McCarty CA. The VECAT study: Methodology and statistical power for measurement of age-related macular features. Ophthalmic Epidemiology. 1999;6:181-194.
77. The Age-Related Eye Disease Study (AREDS): Design implications AREDS report no. 1. The Age-Related Eye Disease Study Research Group. Control Clin Trials. 1999;20:573-600.
78. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. AREDS report no.8. Arch Ophthalmol. 2001;119:1147-1436.
79. Albanes D, Heinonen OP, Huttunen JK, Taylor PR, Virtamo J, Edwards BK, Haapakoski J, Rautalahti M, Hartman AM, Palmgren J. Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study. Am J Clin Nutr. 1995;62(Suppl 6):1427S-1430S.
80. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL Jr, Valanis B, Williams JH Jr, Barnhart S, Cherniack MG, Brodkin CA, Hammar S. Risk factors for lung cancer and forintervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. JNatl Cancer Inst. 1996;88:1550-1559.
81. Burton GW, Ingold KU. Beta-Carotene: An unusual type of lipid antioxidant. Science. 1984;224:569-573.
82. Young AJ, Lowe GM. Antioxidant and prooxidant properties of carotenoids. Arch Biochem. Biophys. 2001;385:20-27.
83. Mannisto S, Smith-Warner SA, Spiegelman D, Albanes D, Anderson K, van den Brandt PA, Cerhan JR, Colditz G, Feskanich D, Freudenheim JL, Giovannucci E, Goldbohm RA, Graham S, Miller AB, Rohan TE, Virtamo J, Willett WC, Hunter DJ. Dietary carotenoids and risk of lung cancer in a pooled analysis of seven cohort studies. Cancer Epidemiol Biomarkers Prev. 2004;13:40-48.
84. Falsini B, Piccardi M, Iarossi G, Fadda A, Merendino E, Valentini P. Influence of short-term antioxidant supplementation on macular function in age-related maculopathy: A pilot study including electrophysiologic assessment. Ophthalmology. 2003;110:51-60:discussion 61.
85. Riggs J. Competing mortality risks and differential survival. J Clin Epidemiol. 1995;48:1087-1088.
86. Broekmans WMR, Berendschot TTJM, Klöpping-Ketelaars IAA, de Vries AJ, Goldbohm RA, Tijburg LBM, Kardinaal AFM, van Poppel G. Macular pigment density in relation to serum and adipose tissue concentrations of lutein and serum concentrations of zeaxanthin. Am J Clin Nutr. 2002;76:595-603.
87. El-Sohemy, Baylin A, Kabagambe E, Ascherio A, Spiegelman D, Campos H. Individual carotenoid concentrations in adipose tissue and plasma as biomarkers of dietary intake. Am J Clin Nutr. 2002;76:172-179.
88. Johnson EJ, Hammond BR, Yeum KJ, Qin J, Wang XD, Castaneda C, Snodderly DM, Russell RM. Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density. Am J Clin Nutr. 2000;71:1555-1562.
89. Pollard J, Wild CP, White KL, Greenwood DC, Cade JE, Kirk SF. Comparison of plasma biomarkers with dietary assessment methods for fruit and vegetable intake. Eur J Clin Nutr. 2003;57:988-998.
90. Van Kappel AL, Steghens JP, Zeleniuch-Jacquotte A, Chajes V, Toni P, Riboli E. Serum carotenoids as biomarkers of fruit and vegetable consumption in the New York Women's Health Study. Public Health Nutr. 2001;4:829-835.
91. Potischman N. Biologic and methodologic issues for nutritional biomarkers. J Nutr. 2003;133:8758-8808.
92. Block G, Sinha R, Gridley G. Collection of dietary-supplement data and implications for analysis. Am J Clin Nutr. 1994;59(1 Suppl):232S-239S.
93. Lyle BJ, Mares-Perlman JA, Klein BEK, Klein R, Greger JL. Supplement users differ from nonusers in demographic, lifestyle, dietary and health characteristics. J Nutr. 1998;128:2355-2362.
94. Lanchoney DM, Maguire MG, Fine SL. A model of the incidence and consequences of choroidal neovascularization secondary to age-related macular degeneration: Comparative effects of current treatment and potential prophylaxis on visual outcomes in high-risk patients. Arch Ophthalmol. 1998;116:1045-1052.